bendamustine hydrochloride
Commercial- Indications
- Chronic lymphocytic leukemia
Company intelligence / Profile preview
Cephalon, Inc.
Frazer, Pennsylvania, United Statescephalon.eu ↗
- Ownership
- Public · TEVA
- Employees
- ~3000
- Development stage
- Commercial
01
Overview
Cephalon developed several first-in-class or best-in-class products including Provigil® (modafinil) for narcolepsy and related disorders; Actiq® and Fentora® for breakthrough cancer pain; Nuvigil® (armodafinil); Treanda® for hematologic cancers. The company also advanced pipeline assets in oncology and neurology. By the time of its acquisition by Teva Pharmaceutical Industries Ltd. in 2011 for $6.8 billion, it had annual sales exceeding $2 billion with a robust international presence[2][5][7].
- Therapeutic areas
- OncologyPulmonologyNeurology
- Modalities
- Small molecules (e.g., modafinil/armodafinil)monoclonal antibodies (e.g., reslizumab)extended-release formulations
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Schering-Plough ($20M Alzheimer's research deal)TAP HoldingsKyowa Hakko KogyoH Lundbeck A/SR.W. Johnson Pharmaceutical Research Institute among others during its independent years[3][6].
Beyond the preview
Go deeper on Cephalon, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cephalon, Inc..